← Home / Amgen Inc. (AMGN)
Stock Analysis
Amgen Inc. (AMGN)
AMGN
AMGN · Healthcare • Biotech
387.64 +0.00%
Track AMGN in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when AMGN price is:
52W Range Position
96%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-07-31 11:44 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 393.10. Holding above 360.13 keeps the current thesis intact.
⚖️
✓
Fundamentals
Moderate / Strong
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
360.13
↗
Break Above
Confirmation improves above resistance.
393.10
🎯
Next Objective
Pattern-derived target if setup continues.
434.42
×
Thesis Break
Scenario weakens below invalidation.
Below 360.13
Recent Company Events
SEC VERIFIED
Latest material filings
MAY
19
●
Management / Board
MEDIUM
AMGN board and management update
Griffith, Chief Financial Officer On May 19, 2026, Amgen Inc.
8-K Filing • SEC EDGAR
APR
30
●
Financial Results
HIGH
AMGEN REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
30, 2026) - Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2026.
8-K Filing • SEC EDGAR
What's Driving AMGN?
📈 Technical recovery is improving
Momentum is Neutral. Watch 393.10 for confirmation and 360.13 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 360.13 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Pattern
Cup With Handle · Confirmed
Trigger
375.25
Target
434.42
Invalidation
353.95
Pattern
Triangle Compression / SYM / UP
State
Back Inside
Trigger
373.15
Risk / Invalid
344.59
Compression
13%
◎
How to read this setup
Active technical structure detected. Use the chart overlays, support, resistance and invalidation levels to manage confirmation and risk.
Price Chart
AMGN — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-30
Fair
Fair valuation
Valuation looks broadly balanced for a mature quality business.
Market Cap
$209.2B
Company size
EV
$259.9B
Debt-adjusted value
P/E
26.8
Reasonable
P/S
5.6
Balanced
P/B
22.8
Very high
EV/Sales
7.0
Balanced
EV/EBIT
24.6
Reasonable
P/FCF
24.3
Reasonable
FCF Yield
4.11%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Strong execution with elevated leverage
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Moderate
●
Profitability
Strong
≈
Cash Flow
Healthy
⚖
Balance Sheet
Stretched
💵 Revenue
8.62B
≈ Moderate
📈 Net Income
1.82B
↗ Strong
🧮 EPS (Basic)
3.37
↗ Strong
Amgen Inc.
Healthcare • Biotech
Related Opportunities